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As concerns the comment about the results of our study (I) in 
patients with a previous myocardiai infarction, we assessed the efficacy 
One consideratton that Cheng adduced for his argument that all 
of the three tests in detecting the extent of coronary artery disease: The 
patients with mitral valve prolapse should receive prophylaxis was that 
accuracy values, not the sensitivity, in predicting the extent of coronary 
“antibiotic prophylaxis against infective endocarditis is highly cost-, 
artery disease were 71% fsr exe&e. 75% for dobutamine and 33% for 
effective,” quoting Gould and Buckingham (4). Analysis of the latter 
dipyridamole. 
report suggests that this conclusion i- fat from sccuri. 
First. Gould and Buckingham conceded that “there is no direct 
Again, from a c!inica! perspective and after personal experience 
spanning nearly two decades, our view is that exercise testing firmly 
bears comparison with the easier to perform pharmacologic stress. 
Physical exertion is a better stress than dipyridamole, dobutamine and 
pacing according to a recent experimental study (7) in that it causes the 
most severe contractile dysfunction, and in clinical practice it main- 
tains the unique capability of providing physiologic information on the 
patient’s exercise capacity. Pharmacologic stress echocardiography, 
notably using dobutamine, could thus supplement rather than supplant 
the more traditional diagnostic role of exercise testing in the evalua- 
tion of chest pain. In light of the tangible difference between 
dipyridamole- and exercise-induced ischemic phenomena, dipyrida- 
mole being the coronary vasodilator liable to trigger ischemia in 
circumstances where no other physiologic activity can elicit the same 
response, in our opinion it is proper to wonder whether dipyridamole 
may be put to fruitful clinical use either as a means of diagnosing 
myocardial ischemia or as a valid tool for prognosis. 
proof that antibiotic prophylaxis is efficacious.” Lacking that, there is 
no way to prove their assertion that it is highly cost-effective. Second, 
they askcrtor’ that 15% of cases of infective endocarditis ere attribut- 
able tc drntrl procedures, citing an article by Bayliss et al. (5). Bayliss 
et al. rcgorted a figure of 13.7% for cases that occurred as long as 3 
months after a dental procedure. Three weeks would have been a more 
appropriate interval, according to Starkebaum et al. (6) who found 
that symptoms began within 2 weeks in 84% of the cases that they 
studied. When Bayliss et al. used an interval of c;l month to link a 
dental procedure with endocarditis, only 3.7% could be attributed to 
the dental procedure. This is nearly identical to the ra,< of 3.6% that 
I found after a literature search that included 1.322 cases (7). Another 
consideration in calculating the effectiveness of prophylaxis is the 
number of endocarditis cases with known heart disease before the 
infection, and that was only 42.5% (i.e.. only 1.64 of all cases of 
endocarditis could have been prevented if prophylaxis had &en 
successful). Considering that a number of cases that have had prophy- 
laxis nevertheless develop endocarditis even when the offending 
organism was susceptible to the antibiotic used (8), the percent ofceses 
of endocarditis that could be prevented is surely <1.5%. This small 
number may explain why the incidence of endocarditis has not changed 
significantly since the introduction of chemoprophylaxis (S), which 
caused Bayliss et al. to argue that better dental care and hygiene are 
much more important than chemoprophylaxis. 
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Nevertheless. all the studies mentioned here advocate chemopro- 
phylaxis for dental procedures. One good reason is to avoid litigation. 
At the least, we should make prophylaxis as simple as possible. 
Fortunately, the American Heart Association in 1991 abandoned their 
recommendation for intravenous antibiotics for high risk patients 
which was never practical for most parts of the countrv. It is alw 
reasonable to abandon the second dose of amoxicillim,~in that the 
proven duration of bacteremia after extraction is only 15 mm (7). The 
British have used only a single dose for some years (5). But for 
cost-effectiveness, chemoprophylaxis should receive a lower priority 
from cardiologists than good dental health. 
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questions that we have all stru&d with. Should we recommend 
antibiotics for all such patients or only for those who demonstrate 
audible murmurs of mitral regngitation. as recommended by the 
American Heart Association gutdelirtes (3)? (What about the many 
patients who have no clii no audible murmur and no prolapse but 
have mild mitral regurgitation by Doppler at test?) 
